Smith & Nephew plc (LON:SN)
1,416.00
+6.00 (0.43%)
Sep 5, 2025, 4:35 PM BST
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.96B USD in the half year ending June 28, 2025, with 8.30% growth. This brings the company's revenue in the last twelve months to $5.94B, up 5.35% year-over-year. In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth.
Revenue (ttm)
$5.94B
Revenue Growth
+5.35%
P/S Ratio
2.84
Revenue / Employee
$342.61K
Employees
17,349
Market Cap
12.30B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 671.60M |
Oxford Nanopore Technologies | 204.69M |
Smith & Nephew News
- 2 days ago - What Does the Market Think About Smith & Nephew? - Benzinga
- 2 days ago - Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System - GlobeNewsWire
- 4 weeks ago - Smith & Nephew: Doing Better And Still Offers Value - Seeking Alpha
- 4 weeks ago - Smith & Nephew plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Top 2 Health Care Stocks You May Want To Dump In Q3 - Benzinga
- 4 weeks ago - Smith & Nephew Non-GAAP EPS of $0.43, revenue of $2.96B; reaffirms FY outlook - Seeking Alpha
- 4 weeks ago - FTSE Opens Higher as Smith & Nephew Rallies on Strong Results - Investomania